Close Menu

 

NEW YORK (360Dx) – Thermo Fisher Scientific received 510(k) clearance from the US Food and Drug Administration last month for its assay for assessing patients suspected of having sepsis, one of a number of diagnostic tests that the agency cleared for marketing in June.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.